Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Exposure-Response Analyses of Various Efficacy and Safety Endpoints in Support of Registrational Dose Selection of Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma

Oleg Milberg, Joannellyn Chiu, Anasuya Hazra, Sameer Upadhyay, Glenn S. Kroog, Karen Rodriguez Lorenc, John D. Davis, A. Thomas DiCioccio, Lutz O. Harnisch, Jason Chittenden

Blood (2024) 144 (Supplement 1): 7056.

https://doi.org/10.1182/blood-2024-200109

Published: 2024

Journal Articles

Soluble BCMA Dynamics in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in Linker-MM1

Anasuya Hazra, Anita Boyapati, Ching-Ha Lai, Kate Knorr, Dhruti Chokshi, Glenn S. Kroog, Karen Rodriguez Lorenc, A. Thomas DiCioccio, John D. Davis

Blood (2024) 144 (Supplement 1): 3310.

https://doi.org/10.1182/blood-2024-200880

Published: 2024

Journal Articles

Evaluate Dynamics of IL-6 Release during Step-up Dosing of Subcutaneous Administration of Odronextamab Via a Quantitative Systems Pharmacology Modeling Approach

Masood Khaksar Toroghi, Min Zhu, Srikanth R. Ambati, Hesham Mohamed, Aafia Chaudhry, Hong Yan, John D. Davis, A. Thomas DiCioccio

Blood (2022) 140 (Supplement 1): 11912–11913.

https://doi.org/10.1182/blood-2022-158413

Published: 2022

Journal Articles

A Quantitative Systems Pharmacology Modeling Framework for Evaluation of Cytokine Release Mediated By Intravenous Odronextamab Monotherapy in Patients with B-Cell Non-Hodgkin Lymphoma

Masood Khaksar Toroghi, Min Zhu, Jurriaan Brouwer-Visser, Srikanth R. Ambati, Hesham Mohamed, Aafia Chaudhry, John D. Davis, A. Thomas DiCioccio

Blood (2022) 140 (Supplement 1): 11930–11931.

https://doi.org/10.1182/blood-2022-158412

Published: 2022